Surgery without an incision is now a possibility. The new Transoral Incisionless Fundoplication procedure, or TIF, using the innovative EsophyX® device for the treatment of gastroesophageal reflux disease (GERD) is now available at Good Samaritan Medical Center.
“The TIF procedure can significantly improve quality of life for our patients,” said Dr. Kimmerle Cohen, Oncological And Hepatopancreaticobiliary surgeon at Good Samaritan Medical Center. “GERD is an anatomical problem which needs an anatomical solution. Reflux medication like PPIs (proton pump inhibitors) can help relieve patients’ heartburn symptoms but don’t solve the underlying anatomical problems or prevent further disease progression. Even on PPIs many patients are still unable to eat the foods they want or have to sleep sitting up to reduce nighttime reflux. In addition, recent studies have shown that long- term use of PPIs can lead to inadequate absorption of minerals such as calcium and can result in bone fractures. After the TIF procedure, clinical trials show that most patients can eat and drink foods they avoided for many years. Reflux no longer impacts their life like it previously did.”
The TIF procedure is based on established principles of surgical repair of the antireflux barrier, except that it is “surgery from within” performed transorally (through the mouth). The procedure reduces hiatal hernia and re-establishes the high pressure zone between the stomach and esophagus restoring the natural, physiological anatomy to prevent gastroesophageal reflux. Because the procedure is incisionless, there is reduced pain, reduced recovery and no visible scar.
